- Cardinal Health (NYSE:CAH) reported a strong adjusted EPS of $2.91, significantly beating the Zacks Consensus Estimate of $2.42 by 20.25%.
- Despite missing revenue consensus by 2.96% with $63.7 billion, the company still achieved 6% year-over-year revenue growth.
- A one-time tariff refund of $0.31 boosted EPS, but core operations still demonstrated robust 25% growth in non-GAAP diluted EPS.
Cardinal Health (NYSE:CAH) is a major company in the healthcare sector. It distributes pharmaceuticals and medical products, operating within the Medical - Dental Supplies industry. The company plays a key role in the healthcare supply chain, connecting drug manufacturers with pharmacies, hospitals, and other care providers.
For its fourth quarter, Cardinal Health reports an adjusted earnings per share (EPS) of $2.91. This figure surpasses the Zacks Consensus Estimate of $2.42 by 20.25%. This performance also shows a substantial increase from the $2.08 per share reported in the same quarter of the previous year, continuing a trend of beating EPS estimates.
A key factor in the strong earnings was a one-time tariff refund, as highlighted by Barrons. Excluding this positive impact of $0.31, the non-GAAP diluted EPS was $2.60. This still represents a 25% increase, showing growth in the company's core operations even without the one-time event.
On the revenue side, Cardinal Health posted revenues of $63.7 billion for the quarter. This amount fell short of the consensus estimate of $65.15 billion, missing expectations by 2.96%. This indicates that while earnings were strong, the company's total sales did not meet analyst forecasts for the period.
Despite missing the estimate, the company's revenue shows year-over-year growth. The reported $63.7 billion is a 6% increase from the $60.16 billion generated in the year-ago quarter. This demonstrates that the company's sales are expanding, even if they did not reach the projected target for this quarter.